Your browser doesn't support javascript.
loading
Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in Japan.
Matsumoto, Tetsuya; Mikamo, Hiroshige; Ohge, Hiroki; Yanagihara, Katsunori; Weerdenburg, Eveline; Go, Oscar; Spiessens, Bart; van Geet, Gunter; van den Hoven, Thijs; Momose, Atsushi; Hagiwara, Yosuke; Nakayama, Yoshikazu; Poolman, Jan; Geurtsen, Jeroen; Kaku, Mitsuo.
Afiliación
  • Matsumoto T; Department of Infectious Diseases, International University of Health and Welfare, Chiba, Japan; Department of Microbiology, Tokyo Medical University, Tokyo, Japan. Electronic address: tetsuya.m@iuhw.ac.jp.
  • Mikamo H; Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Aichi, Japan. Electronic address: mikamo@aichi-med-u.ac.jp.
  • Ohge H; Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan. Electronic address: ohge@hiroshima-u.ac.jp.
  • Yanagihara K; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Electronic address: k-yanagi@nagasaki-u.ac.jp.
  • Weerdenburg E; Janssen Vaccines & Prevention, Leiden, the Netherlands. Electronic address: eweerden@its.jnj.com.
  • Go O; Janssen Research & Development, Raritan, NJ, USA. Electronic address: OGo@its.jnj.com.
  • Spiessens B; Janssen Research & Development, Beerse, Belgium. Electronic address: bspiesse@its.jnj.com.
  • van Geet G; Janssen Integrated Data Analytics & Reporting, Beerse, Belgium. Electronic address: gvangeet@its.jnj.com.
  • van den Hoven T; Janssen Integrated Data Analytics & Reporting, Beerse, Belgium. Electronic address: THoven1@its.jnj.com.
  • Momose A; Janssen Pharmaceutical K. K., Chiyoda-ku, Tokyo, Japan. Electronic address: amomose@its.jnj.com.
  • Hagiwara Y; Janssen Pharmaceutical K. K., Chiyoda-ku, Tokyo, Japan. Electronic address: yhagiwar@its.jnj.com.
  • Nakayama Y; Janssen Pharmaceutical K. K., Chiyoda-ku, Tokyo, Japan. Electronic address: ynakaya3@its.jnj.com.
  • Poolman J; Janssen Vaccines & Prevention, Leiden, the Netherlands. Electronic address: JPoolman@its.jnj.com.
  • Geurtsen J; Janssen Vaccines & Prevention, Leiden, the Netherlands. Electronic address: jgeurtse@its.jnj.com.
  • Kaku M; Division of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University, Miyagi, Japan. Electronic address: kaku-m77@med.tohoku.ac.jp.
J Infect Chemother ; 28(11): 1445-1451, 2022 Nov.
Article en En | MEDLINE | ID: mdl-35843539
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Bacteriemia / Infecciones por Escherichia coli / Escherichia coli Patógena Extraintestinal / Antiinfecciosos Tipo de estudio: Observational_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Bacteriemia / Infecciones por Escherichia coli / Escherichia coli Patógena Extraintestinal / Antiinfecciosos Tipo de estudio: Observational_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article